VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $22.03 million. The enterprise value is $32.38 million.

Market Cap	22.03M
Enterprise Value	32.38M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 7.92 million shares outstanding. The number of shares has increased by 23.46% in one year.

Current Share Class	7.92M
Shares Outstanding	7.92M
Shares Change (YoY)	+23.46%
Shares Change (QoQ)	+11.80%
Owned by Insiders (%)	98.71%
Owned by Institutions (%)	303.82%
Float	137.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.75
Forward PS	9.17
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	18.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.73

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-166.70%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	407.89%
Weighted Average Cost of Capital (WACC)	13.47%
Revenue Per Employee	$23,032
Profits Per Employee	-$311,427
Employee Count	75
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.46% in the last 52 weeks. The beta is 1.33, so VolitionRx's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-71.46%
50-Day Moving Average	3.74
200-Day Moving Average	7.89
Relative Strength Index (RSI)	31.72
Average Volume (20 Days)	195,391

Short Selling Information

Short Interest	8.07M
Short Previous Month	1.42M
Short % of Shares Out	n/a
Short % of Float	5.87%
Short Ratio (days to cover)	0.31

Income Statement

In the last 12 months, VolitionRx had revenue of $1.73 million and -$23.36 million in losses. Loss per share was -$4.37.

Revenue	1.73M
Gross Profit	1.73M
Operating Income	-21.74M
Pretax Income	-23.50M
Net Income	-23.36M
EBITDA	-20.75M
EBIT	-21.74M
Loss Per Share	-$4.37

Full Income Statement

Balance Sheet

The company has $1.12 million in cash and $11.46 million in debt, giving a net cash position of -$10.35 million or -$1.31 per share.

Cash & Cash Equivalents	1.12M
Total Debt	11.46M
Net Cash	-10.35M
Net Cash Per Share	-$1.31
Equity (Book Value)	-35.59M
Book Value Per Share	-5.45
Working Capital	-10.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.68 million and capital expenditures -$89,558, giving a free cash flow of -$19.77 million.

Operating Cash Flow	-19.68M
Capital Expenditures	-89,558
Depreciation & Amortization	983,706
Net Borrowing	6.02M
Free Cash Flow	-19.77M
FCF Per Share	-$2.50

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,258.47%
Pretax Margin	-1,360.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.46%
Shareholder Yield	-23.46%
Earnings Yield	-106.03%
FCF Yield	-89.76%

Analyst Forecast

The average price target for VolitionRx is $1.67, which is -39.93% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$1.67
Price Target Difference	-39.93%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	96.78%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 28, 2026. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 28, 2026
Split Type	Reverse
Split Ratio	1:20

Scores

VolitionRx has an Altman Z-Score of -62.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-62.41
Piotroski F-Score	2